MVM Partners, LLC, a ten percent owner of Paragon 28 , Inc. (NYSE:FNA), recently disclosed the sale of 45,162 shares of the company's common stock. The transactions occurred over two consecutive ...

On January 27, MVM Partners sold 27,142 shares at $11.6213 per share, followed by a larger sale of 84,323 shares on January 28 at $11.938 per share. Following these transactions, MVM Partners ...

BOSTON & LONDON--(BUSINESS WIRE)--MVM Partners is pleased to announce the closing of its sixth healthcare fund, MVM VI, with $500 million in limited partner commitments. Demand was well above the ...

BOSTON & LONDON--(BUSINESS WIRE)--MVM Partners today announced the closing of a $325 million healthcare fund, MVM V. MVM has been investing in high growth healthcare businesses since 1997 and this ...

The funding firm MVM Life Science Partners, which is behind the creation and development of a number of big biotechs, has raised $233 million in its fourth and largest funding round to date.

MVM Life Science Partners today announced the closing of a $233 million healthcare fund, MVM IV. The fund is MVM’s fourth and largest raised to date. MVM IV is investing in medical companies ...